Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...

Executives from Pfizer Inc and Amazon.com see opportunities for working with U.S. health secretary nominee Robert F. Kennedy Jr to manage growing health risks in a warming world. Amazon ...

Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own Chris Boshoff, M.D., Ph.D., for the job and prompting a domino ...

Fresh from the $43 billion acquisition of antibody-drug conjugate (ADC) specialist Seagen, Pfizer has laid out plans for its dedicated oncology division in front of investors, aiming to add eight ...

Pfizer said its chief oncology officer, Chris Boshoff, will head all of the company’s research and development efforts in addition to keeping his current duties overseeing the company’s ...

Pfizer will work with Ampersand Biomedicines and Montai Therapeutics to find drugs for lung cancer and obesity, adding to collaborations it formed with other Flagship startups earlier this year.

Pfizer PFE1.44%increase; green up pointing triangle elevated the executive in charge of its cancer-drugs business to oversee all of the drugmaker’s research and development, a crucial move at a ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD ...

Bonus Jun 12, 2000 Jun 28, 2000 May 25, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus--Jul 25, 1977 Bonus Ratio: 4 share(s) for every 5 shares held Bonus--Jul 25, 1972 Bonus Ratio: 2 ...

Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer while it works to fend off activist criticism that its pipeline is underwhelming. Boshoff ...

NEW YORK, Nov 19 (Reuters) - A federal judge on Tuesday rejected Pfizer's (PFE.N), opens new tab bid to recoup about $75.2 million left over from a U.S. Securities and Exchange Commission insider ...